Alnylam Gets Orphan Drug Status for Potential Treatment for Rare …

Published June 22, 2012

Alnylam gets orphan drug status for potential treatment for rare …

Filed under: Drug Rehab Centers Washington D.C.

Alnylam Pharmaceuticals Inc. said Tuesday that it received special regulatory incentives for a drug designed to treat a potentially fatal neurodegenerative …
Read more on Greenfield Daily Reporter

Collaboration Between Sanofi And Joslin Diabetes Center To Focus …

Filed under: Drug Rehab Centers Washington D.C.

… promote the development of new medicines for the treatment of diabetes and related … Joslin Diabetes Center is the world's leading diabetes research and clinical care … whether and when to approve any drug, device or biological application that …
Read more on Daily Markets (press release)

I-SPY 2 Trial Results in Proposed Accelerated FDA Approval Path …

Filed under: Drug Rehab Centers Washington D.C.

(Washington, D.C.) I-SPY 2 (Investigation of Serial Studies to Predict Your … new drugs in high risk breast cancers in the neoadjuvant (drug treatment prior to … Buck Breast Care Center at the University of California, San Francisco Helen Diller …
Read more on NCTechNews (press release)